These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18087188)

  • 1. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?
    Zhou P; Kudo M; Minami Y; Chung H; Inoue T; Fukunaga T; Maekawa K
    Oncology; 2007; 72 Suppl 1():92-7. PubMed ID: 18087188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
    Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma.
    Nouso K; Shiraga K; Uematsu S; Okamoto R; Harada R; Takayama S; Kawai W; Kimura S; Ueki T; Okano N; Nakagawa M; Mizuno M; Araki Y; Shiratori Y
    Liver Int; 2005 Oct; 25(5):967-72. PubMed ID: 16162154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.
    Hiraoka A; Hirooka M; Koizumi Y; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Michitaka K; Horiike N; Yamashita Y; Hiasa Y; Matsuura B; Onji M
    Oncol Rep; 2010 Feb; 23(2):493-7. PubMed ID: 20043112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Hepatogastroenterology; 2011; 58(110-111):1638-42. PubMed ID: 22086693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
    Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
    Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
    Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
    Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
    Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
    Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
    Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
    AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules.
    Sato S; Miyake T; Mishiro T; Furuta K; Azumi T; Oshima N; Takahashi Y; Rumi MA; Ishihara S; Adachi K; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1714-9. PubMed ID: 16984595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma.
    Hotta N; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2006; 53(70):521-5. PubMed ID: 16995453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.